The differences in the expression of hormonal receptors (ER/PR), human epidermal growth factor receptor 2 (HER2), Ki67 proliferation index and gene expression profiles among patients has enabled the classification of breast cancer into distinct subtypes: Luminal A, Luminal B, HER2 + and TNBC (1–4). This evidence concerns the gene ERBB2 and breast cancer.